Mucosal adjuvants

AM Harandi, D Medaglini - Current HIV research, 2010 - ingentaconnect.com
The vast majority of pathogens invade the body through or establish infections in the
mucosal tissues. Development of vaccines to combat mucosal infections represents a top …

Mucosal Adjuvants

AM Harandi, D Medaglini - Current HIV Research, 2010 - hero.epa.gov
The vast majority of pathogens invade the body through or establish infections in the
mucosal tissues. Development of vaccines to combat mucosal infections represents a top …

Mucosal adjuvants.

AM Harandi, D Medaglini - Current HIV Research, 2010 - europepmc.org
The vast majority of pathogens invade the body through or establish infections in the
mucosal tissues. Development of vaccines to combat mucosal infections represents a top …

Mucosal adjuvants

AM Harandi, D Medaglini - Current HIV research, 2010 - pubmed.ncbi.nlm.nih.gov
The vast majority of pathogens invade the body through or establish infections in the
mucosal tissues. Development of vaccines to combat mucosal infections represents a top …

Mucosal adjuvants.

AM Harandi, D Medaglini - 2010 - cabidigitallibrary.org
The vast majority of pathogens invade the body through or establish infections in the
mucosal tissues. Development of vaccines to combat mucosal infections represents a top …

Mucosal adjuvants

A Harandi, D Medaglini - CURRENT HIV RESEARCH, 2010 - usiena-air.unisi.it
The vast majority of pathogens invade the body through or establish infections in the
mucosal tissues. Development of vaccines to combat mucosal infections represents a top …

[引用][C] Mucosal Adjuvants

AM Harandi, D Medaglini - Current HIV Research, 2010 - cir.nii.ac.jp
Mucosal Adjuvants | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細
へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす …